➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 22, 2021

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: Cipla Ltd

Email this page to a colleague

« Back to Dashboard

Cipla Ltd Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Free Forever Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Cipla Ltd	darunavir	207189	150MG	TABLET;ORAL
Cipla Ltd	darunavir	206288	75MG	TABLET;ORAL
Cipla Ltd	darunavir	207189	75MG	TABLET;ORAL
Cipla Ltd	lamivudine; nevirapine; zidovudine	203076	30MG; 50MG; 60MG	TABLET; ORAL SUSPENSION
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.